BioLife Solutions, Inc. (BLFS) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.75M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 9.77M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.75M | (m) | (m) | $9.77M | (m) | (m) |
| 2026-03-31 | $-16.08M | (m) | (m) | $8.78M | (m) | (m) |
| 2025-12-31 | $-16.60M | (m) | (m) | $7.57M | (m) | (m) |
| 2025-09-30 | $-20.06M | (m) | (m) | $9.55M | (m) | (m) |
| 2025-06-30 | $-20.39M | (m) | (m) | $8.73M | (m) | (m) |
| 2025-03-31 | $-5.05M | (m) | (m) | $8.04M | (m) | (m) |
| 2024-12-31 | $-7.13M | (m) | (m) | $7.91M | (m) | (m) |
| 2024-09-30 | $-44.60M | (m) | (m) | $14.85M | (m) | (m) |
| 2024-06-30 | $-58.52M | (m) | (m) | $16.54M | (m) | (m) |
| 2024-03-31 | $-67.35M | (m) | (m) | $18.18M | (m) | (m) |
| 2023-12-31 | $-70.83M | (m) | (m) | $18.80M | (m) | (m) |
| 2023-09-30 | $-106.94M | (m) | (m) | $18.56M | (m) | (m) |
| 2023-06-30 | $-89.90M | (m) | (m) | $16.58M | (m) | (m) |
| 2023-03-31 | $-151.18M | (m) | (m) | $15.17M | (m) | (m) |
| 2022-12-31 | $-145.54M | (m) | (m) | $14.80M | (m) | (m) |
| 2022-09-30 | $-112.55M | (m) | (m) | $14.21M | (m) | (m) |
| 2022-06-30 | $-112.30M | (m) | (m) | $14.00M | (m) | (m) |
| 2022-03-31 | $-40.59M | (m) | (m) | $13.62M | (m) | (m) |
| 2021-12-31 | $-33.94M | (m) | (m) | $11.82M | (m) | (m) |
| 2021-09-30 | $-21.44M | (m) | (m) | $10.11M | (m) | (m) |
| 2021-06-30 | $-11.52M | (m) | (m) | $8.61M | (m) | (m) |
| 2021-03-31 | $-6.93M | (m) | (m) | $7.04M | (m) | (m) |
| 2020-12-31 | $-5.58M | (m) | (m) | $6.72M | (m) | (m) |
| 2020-09-30 | $-1.59M | (m) | $16.94M | $5.95M | (m) | (m) |
| 2020-06-30 | $-1.12M | (m) | $14.21M | $5.26M | (m) | (m) |
| 2020-03-31 | $-416.00K | (m) | $11.68M | $4.47M | (m) | (m) |
| 2019-12-31 | $-220.00K | (m) | $8.76M | $3.17M | (m) | (m) |
| 2019-09-30 | $1.86M | (m) | $7.40M | $2.73M | (m) | (m) |
| 2019-06-30 | $3.65M | (m) | $6.92M | $1.74M | (m) | (m) |
| 2019-03-31 | $4.01M | (m) | $6.50M | $1.32M | (m) | (m) |
| 2018-12-31 | $3.66M | (m) | $6.22M | $1.30M | (m) | (m) |
| 2018-09-30 | $2.40M | (m) | $5.80M | $1.28M | (m) | (m) |
| 2018-06-30 | $1.17M | (m) | $5.29M | $1.26M | (m) | (m) |
| 2018-03-31 | $-452.09K | (m) | $4.71M | $1.25M | (m) | (m) |
| 2017-12-31 | $-1.06M | (m) | $4.28M | $1.19M | (m) | (m) |
| 2017-09-30 | $-1.46M | (m) | $3.86M | $1.33M | (m) | (m) |
| 2017-06-30 | $-2.57M | (m) | $3.69M | $1.53M | (m) | (m) |
| 2017-03-31 | $-3.82M | (m) | $3.61M | $1.81M | (m) | (m) |
| 2016-12-31 | $-4.85M | (m) | $3.45M | $2.03M | (m) | (m) |
| 2016-09-30 | $-5.63M | (m) | $3.24M | $2.03M | (m) | (m) |
| 2016-06-30 | $-5.79M | (m) | $2.98M | $1.86M | (m) | (m) |
| 2016-03-31 | $-5.35M | (m) | $2.79M | $1.56M | (m) | (m) |
| 2015-12-31 | $-5.02M | (m) | $2.63M | $1.38M | (m) | (m) |
| 2015-09-30 | $-4.62M | (m) | $2.63M | $1.31M | (m) | (m) |
| 2015-06-30 | $-4.20M | (m) | $2.62M | $1.13M | (m) | (m) |
| 2015-03-31 | $-3.93M | (m) | $2.61M | $1.03M | (m) | (m) |
| 2014-12-31 | $-3.14M | $6.19M | $3.16M | $871.10K | (m) | -50.65% |
| 2014-09-30 | $-2.42M | $6.81M | $3.85M | $639.80K | (m) | -35.48% |
| 2014-06-30 | $-1.65M | $7.74M | $4.48M | $647.00K | (m) | -21.35% |
| 2014-03-31 | $-846.73K | $8.85M | $5.31M | $549.13K | (m) | -9.56% |
| 2013-12-31 | $-285.36K | $8.95M | $5.19M | $487.82K | (m) | -3.19% |
| 2013-09-30 | $-308.24K | $8.71M | $5.11M | $471.20K | (m) | -3.54% |
| 2013-06-30 | $-346.86K | $8.22M | $4.92M | $421.37K | (m) | -4.22% |
| 2013-03-31 | $-570.64K | $6.99M | $4.06M | $453.08K | (m) | -8.17% |
| 2012-12-31 | $-942.24K | $5.66M | $3.37M | $463.64K | (m) | -16.64% |
| 2012-09-30 | $-845.19K | $4.42M | $2.43M | $479.20K | (m) | -19.10% |
| 2012-06-30 | $-981.29K | $3.46M | $1.69M | $467.42K | (m) | -28.37% |
| 2012-03-31 | $-934.67K | $2.98M | $1.33M | $474.18K | (m) | -31.32% |
| 2011-12-31 | $-1.21M | $2.76M | $1.36M | $516.45K | (m) | -43.85% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-1.39M | $2.08M | $1.23M | $318.90K | (m) | -66.98% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |